MetLife (NYSE: MET) insider transactions
In the twelve months to 10 November 2026, executives and directors of MetLife reported 1 open-market sale of 21,312 shares ($1.7m) and 0 open-market purchases, by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Kennard William E | Director | Grant or award | +544 | $94.35 | 48,248 | Form 4 |
| 1 October 2026 | Hubbard Robert Glenn | Director | Grant or award | +941 | $94.35 | 109,132 | Form 4 |
| 1 October 2026 | Glaser Daniel S | Director | Grant or award | +544 | $94.35 | 3,249 | Form 4 |
| 1 October 2026 | Harris Carla A | Director | Grant or award | +544 | $94.35 | 11,701 | Form 4 |
| 1 October 2026 | Johnson Jeh C. | Director | Grant or award | +544 | $94.35 | 10,101 | Form 4 |
| 1 October 2026 | McKenzie Diana | Director | Grant or award | +544 | $94.35 | 25,929 | Form 4 |
| 1 October 2026 | Weinberger Mark A | Director | Grant or award | +544 | — | 19,932 | Form 4 |
| 1 October 2026 | Seitz Michelle | Director | Grant or award | +544 | — | 2,125 | Form 4 |
| 1 October 2026 | Hay Laura J | Director | Grant or award | +544 | $94.35 | 6,901 | Form 4 |
| 1 October 2026 | Mumenthaler Christian Stephane | Director | Grant or award | +544 | $94.35 | 4,018 | Form 4 |
| 8 September 2026 | Kennard William E | Director | Grant or award | +294 | $95.50 | 47,704 | Form 4 |
| 8 September 2026 | Hubbard Robert Glenn | Director | Grant or award | +618 | $95.50 | 108,191 | Form 4 |
| 8 September 2026 | Glaser Daniel S | Director | Grant or award | +10 | $95.50 | 2,705 | Form 4 |
| 8 September 2026 | Harris Carla A | Director | Grant or award | +42 | $95.50 | 11,157 | Form 4 |
| 8 September 2026 | Johnson Jeh C. | Director | Grant or award | +59 | $95.50 | 9,557 | Form 4 |
| 8 September 2026 | Tadros Ramy | President, U.S. Business | Grant or award | +115 | $95.50 | 212,695 | Form 4 |
| 8 September 2026 | McKenzie Diana | Director | Grant or award | +157 | $95.50 | 25,385 | Form 4 |
| 8 September 2026 | Hay Laura J | Director | Grant or award | +39 | $95.50 | 6,357 | Form 4 |
| 8 September 2026 | Mumenthaler Christian Stephane | Director | Grant or award | +21 | $95.50 | 3,474 | Form 4 |
| 31 August 2026 | McCallion John D. | EVP & Chief Financial Officer | Shares withheld for tax | −6,057 | $95.17 | 269,137 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the MetLife page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.